| Azacitidine studied in …STUDIED_INderived200 of 521show all (up to 200) |
|---|
| → studied in | NCT06694454Phase 1/Phase 2 · suspended Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC) · 521 trials list this drug (196 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06763341Phase 1 · recruiting A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07478991Phase 3 · recruiting Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI) · 521 trials list this drug (196 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554393Phase 2 · recruiting Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453903Phase 1 · active not recruiting A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548230Phase 1/Phase 2 · recruiting A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852222Phase 3 · recruiting A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874052Phase 1 · recruiting Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266795Phase 2 · completed A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014489Phase 2 · recruiting A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML · 521 trials list this drug (196 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581002Phase 2/Phase 3 · recruiting A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201066Phase 2 · active not recruiting Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554406Phase 2 · recruiting Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm,Acute Myeloid Leukemia Post Cytotoxic Therapy+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06317649Phase 2 · recruiting Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03588078Phase 1/Phase 2 · completed Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine · 521 trials list this drug (196 active) | — | — | Myeloproliferative Neoplasm,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734990Phase 1/Phase 2 · active not recruiting Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia,Chronic Myelomonocytic Leukemia-0+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828535Phase 1 · not yet recruiting Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagnosed Elderly or Unfit AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955261Phase 2 · recruiting A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06668558Phase 2 · active not recruiting Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07645469Phase 1 · recruiting FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504459Phase 2 · recruiting Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia,Acute Monocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01541280Phase 2 · completed VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530463Phase 2 · active not recruiting Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome · 521 trials list this drug (196 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03471260Phase 1/Phase 2 · recruiting Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies · 521 trials list this drug (196 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Myelodysplastic Syndrome,Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03683433Phase 2 · recruiting Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04128501Phase 2 · active not recruiting Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy,T Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771130Phase 1/Phase 2 · recruiting A Study of BGB-11417 in Participants With Myeloid Malignancies · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05520567Phase 1/Phase 2 · active not recruiting A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05641259Phase 1 · recruiting A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06616636Phase 1 · recruiting A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome) · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07044687Phase 4 · recruiting Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255872Phase 2/Phase 3 · recruiting A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07605949Phase 2 · not yet recruiting Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813390Phase 2 · enrolling by invitation Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522976Phase 2 · active not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia,Myelodysplastic Syndrome with Excess Blasts+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04227847Phase 1 · active not recruiting A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06429098Phase 2 · active not recruiting Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03383575Phase 2 · recruiting Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia,Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05849662Phase 1/Phase 2 · recruiting A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia · 521 trials list this drug (196 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03013998Phase 2/Phase 3 · recruiting Study of Biomarker-Based Treatment of Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04588922Phase 1/Phase 2 · recruiting Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML · 521 trials list this drug (196 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06397027Phase 1 · recruiting A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias · 521 trials list this drug (196 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04803201Phase 2 · recruiting Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma · 521 trials list this drug (196 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,Follicular Helper T-Cell Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05772273NA · recruiting PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07471841Phase 2 · recruiting Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax · 521 trials list this drug (196 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177079Phase 1 · recruiting High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523556Phase 1/Phase 2 · recruiting Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Myeloproliferative Neoplasm,Atypical Chronic Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07163793Phase 2 · active not recruiting Pilot Study of Reduced Venetoclax Exposure · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07388563Phase 1 · suspended Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma · 521 trials list this drug (196 active) | — | — | Lymphoma,Anaplastic Large Cell Lymphoma,Adult T-Cell Leukemia/Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07439211Phase 1 · recruiting Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Leukemia,Myeloid Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07754799Phase 2 · not yet recruiting A Randomized Trial of Venetoclax-Based Induction Intensity in Newly Diagnosed Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06232655Phase 2 · active not recruiting Cladribine Venetoclax in Monocytic AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06514261Phase 1 · suspended Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183035Phase 3 · recruiting Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07773909Phase 4 · completed Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007312Phase 3 · recruiting Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · 521 trials list this drug (196 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma,Adult Nasal Type Extranodal NK/T-Cell Lymphoma,Nasopharyngeal Keratinizing Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148947Phase 2 · recruiting Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms · 521 trials list this drug (196 active) | — | — | Accelerated Phase Myeloproliferative Neoplasm,Blast Phase Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762508NA · not yet recruiting A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06656494Phase 1 · recruiting ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07770698Phase 1/Phase 2 · not yet recruiting A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia · 521 trials list this drug (196 active) | — | — | Childhood Malignant Neoplasm,Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07387354Phase 1/Phase 2 · withdrawn Pacritinib With Aza for Upfront Myelodysplastic Syndrome · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic Syndrome, Unclassifiable,Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04173533Phase 3 · completed Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942290Phase 1 · completed A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS) · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06159491Phase 1/Phase 2 · recruiting Pacritinib in CMML · 521 trials list this drug (196 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07131059NA · recruiting MRD-positive AML Clinical Study · 521 trials list this drug (196 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392353Phase 1/Phase 2 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic Syndrome with Ring Sideroblasts,Acute Erythroid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573024Phase 2 · completed Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06265545NA · recruiting Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07490288NA · recruiting Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06456463Phase 2 · active not recruiting A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06903702Phase 2 · withdrawn A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07746245Phase 2 · not yet recruiting The Efficacy of CAPCT in Patients With PTCL · 521 trials list this drug (196 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284787Phase 2 · active not recruiting BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177067Phase 1 · recruiting Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743112Phase 2 · recruiting A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07679334Phase 1 · not yet recruiting Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms · 521 trials list this drug (196 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03628209Phase 1 · active not recruiting Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma · 521 trials list this drug (196 active) | — | — | Sarcoma,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548710Phase 2 · recruiting Study of SA+X in the Treatment of Newly Diagnosed AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735117Phase 3 · not yet recruiting Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05141682Phase 1/Phase 2 · active not recruiting Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia · 521 trials list this drug (196 active) | — | — | T-Cell Large Granular Lymphocyte Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07722767Phase 1 · not yet recruiting A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04603001Phase 1 · active not recruiting Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392242Phase 2 · recruiting A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Myeloid Neoplasm,Myelodysplastic Syndrome,Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04062266Phase 2 · active not recruiting AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06498973Phase 1 · recruiting Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843528Phase 1 · active not recruiting Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation · 521 trials list this drug (196 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02752035Phase 3 · completed A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158100Phase 1 · terminated Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05442216Phase 2 · recruiting Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691450Phase 1 · not yet recruiting Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma · 521 trials list this drug (196 active) | — | — | Anaplastic Large Cell Lymphoma,Hepatosplenic T-Cell Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04799275Phase 2/Phase 3 · active not recruiting Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma · 521 trials list this drug (196 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma,HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05270200Phase 1/Phase 2 · recruiting Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03895671Phase 2 · completed PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS · 521 trials list this drug (196 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05074355Phase 2 · recruiting Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms · 521 trials list this drug (196 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548983Phase 1 · recruiting Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07304011Phase 2 · recruiting Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357182Phase 1 · recruiting Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia,Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02719574Phase 1/Phase 2 · completed Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173248Phase 3 · active not recruiting Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation · 521 trials list this drug (196 active) | — | — | Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07672769Phase 2 · not yet recruiting Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes · 521 trials list this drug (196 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04090736Phase 3 · active not recruiting Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068597Phase 1/Phase 2 · recruiting Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies · 521 trials list this drug (196 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04891068Phase 2 · recruiting BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer · 521 trials list this drug (196 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05401097Phase 2 · recruiting IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04581512Phase 1/Phase 2 · recruiting Study to Evaluate the Safety and Tolerability of EP0042 · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113643Phase 1 · recruiting SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03703375Phase 3 · completed Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma · 521 trials list this drug (196 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05834244Phase 1 · recruiting A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02993523Phase 3 · active not recruiting A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07635485NA · not yet recruiting VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML · 521 trials list this drug (196 active) | — | — | Secondary Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03146871Phase 2 · terminated Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586609Phase 2 · recruiting Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550442Phase 1/Phase 2 · terminated Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia,Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365035Phase 2 · recruiting A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04161885Phase 3 · terminated A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) · 521 trials list this drug (196 active) | — | — | Malignant Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05162976Phase 1 · active not recruiting CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed · 521 trials list this drug (196 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06370000Phase 4 · recruiting Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445907Phase 1 · active not recruiting Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07404332Phase 1 · recruiting 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors · 521 trials list this drug (196 active) | — | — | Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03613532Phase 1 · active not recruiting Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07598578early Phase 1 · recruiting An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma. · 521 trials list this drug (196 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187703early Phase 1 · recruiting 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05355051Phase 2 · recruiting A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma · 521 trials list this drug (196 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04687761Phase 1/Phase 2 · completed Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06635681Phase 2 · recruiting Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06744556Phase 2 · active not recruiting HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04150887Phase 1 · active not recruiting Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04801797Phase 2 · active not recruiting Venetoclax + Azacitidine vs. Induction Chemotherapy in AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06384261Phase 2 · active not recruiting A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05907057Phase 3 · recruiting An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy. · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05155709Phase 1 · completed A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07573670Phase 2 · not yet recruiting A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia · 521 trials list this drug (196 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05829226Phase 1 · completed A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493138Phase 1/Phase 2 · active not recruiting Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05182957Phase 2 · recruiting Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma · 521 trials list this drug (196 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256317Phase 2/Phase 3 · recruiting A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06497062Phase 2 · active not recruiting Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04501120Phase 1/Phase 2 · recruiting Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML · 521 trials list this drug (196 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05586074Phase 3 · recruiting HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03164057Phase 2 · active not recruiting A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03593018Phase 3 · completed Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL · 521 trials list this drug (196 active) | — | — | Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04435691Phase 1/Phase 2 · terminated Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05428969Phase 1/Phase 2 · active not recruiting A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07320235Phase 1 · recruiting Imetelstat Combinations in Relapsed AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07539818Phase 3 · not yet recruiting Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140487Phase 1/Phase 2 · recruiting Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm · 521 trials list this drug (196 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06782542Phase 2 · recruiting Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554419Phase 2 · not yet recruiting Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) · 521 trials list this drug (196 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469046Phase 3 · not yet recruiting VAH vs VA in Newly Diagnosed Elderly AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04102020Phase 3 · completed A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06419634Phase 1 · recruiting Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02816021Phase 2 · completed Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma · 521 trials list this drug (196 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787487Phase 2 · completed Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm · 521 trials list this drug (196 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified,Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07071155early Phase 1 · recruiting Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia,Chronic Neutrophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04988555Phase 1/Phase 2 · recruiting A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) · 521 trials list this drug (196 active) | — | — | Leukemia,Multiple Myeloma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07486479Phase 3 · not yet recruiting Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07486726Phase 1/Phase 2 · not yet recruiting Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05275439Phase 1 · terminated Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735184Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML · 521 trials list this drug (196 active) | — | — | Myeloid Sarcoma,Acute Myeloid Leukemia,Acute Myeloid Leukemia with NPM1 Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06557421Phase 2 · recruiting De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292664Phase 1 · recruiting Venetoclax Basket Trial for High Risk Hematologic Malignancies · 521 trials list this drug (196 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226418Phase 2 · completed Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07458542active not recruiting Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07060001Phase 2 · not yet recruiting Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132684Phase 3 · recruiting Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients · 521 trials list this drug (196 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06511882Phase 2 · recruiting Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03850418Phase 2 · recruiting Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant · 521 trials list this drug (196 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06773208Phase 2 · recruiting A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML) · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04964505Phase 1 · terminated Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07425808Phase 2/Phase 3 · not yet recruiting FLT3-ITD Targeted Therapy in Fit AML Patients · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02677922Phase 1/Phase 2 · active not recruiting A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04160052Phase 1/Phase 2 · terminated Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia,Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06565975completed Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407660Phase 3 · not yet recruiting Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05197426Phase 2 · active not recruiting A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07018752Phase 1/Phase 2 · recruiting A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas · 521 trials list this drug (196 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148180Phase 1/Phase 2 · recruiting A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax · 521 trials list this drug (196 active) | — | — | Liquid Tumor,Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07372352Phase 2 · recruiting Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL · 521 trials list this drug (196 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03264404Phase 2 · completed Azacitidine and Pembrolizumab in Pancreatic Cancer · 521 trials list this drug (196 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03926624Phase 3 · terminated Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04747236Phase 2 · recruiting Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL · 521 trials list this drug (196 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06429449Phase 1 · recruiting Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Leukemia,Myeloid Leukemia,Acute Monocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06572982NA · active not recruiting Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04150029Phase 2 · terminated A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266301Phase 3 · terminated Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) · 521 trials list this drug (196 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05209295Phase 1 · terminated A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies · 521 trials list this drug (196 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466798Phase 1 · withdrawn Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies · 521 trials list this drug (196 active) | — | — | Central Nervous System Neoplasm,Medulloblastoma,Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03326310Phase 1 · recruiting Selumetinib and Azacitidine in High Risk Chronic Blood Cancers · 521 trials list this drug (196 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869114Phase 2 · completed Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia,Myelodysplastic Syndrome with del(5q)+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02421939Phase 3 · completed A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation · 521 trials list this drug (196 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389292Phase 3 · recruiting A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06647862Phase 3 · recruiting IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2) · 521 trials list this drug (196 active) | — | — | Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566054Phase 2 · recruiting Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia · 521 trials list this drug (196 active) | — | — | Acute Monocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06454409Phase 1 · suspended Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06451861Phase 2 · recruiting Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML · 521 trials list this drug (196 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04937166Phase 1 · terminated A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies · 521 trials list this drug (196 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |